UNRESECTABLE ESOPHAGEAL CARCINOMA
Clinical trials for UNRESECTABLE ESOPHAGEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE ESOPHAGEAL CARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE ESOPHAGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo tested in fight against tough stomach cancers
Disease control CompletedThis study tested a combination of two drugs, olaparib and ramucirumab, for people with advanced stomach or esophageal junction cancers that had spread, returned, or could not be removed by surgery. The main goals were to find a safe dose and see if the combination could shrink t…
Matched conditions: UNRESECTABLE ESOPHAGEAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Could a simple zinc pill ease the hardship of cancer treatment?
Symptom relief CompletedThis small study tested whether taking zinc supplements could improve the day-to-day quality of life for patients with certain hard-to-treat stomach and digestive system cancers while they were undergoing chemotherapy. Researchers wanted to see if preventing zinc deficiency could…
Matched conditions: UNRESECTABLE ESOPHAGEAL CARCINOMA
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Mar 30, 2026 14:31 UTC